Bruce G. Allen Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Buy
6,051
+350
+6% +$16.3K 0.19% 56
2025
Q4
$276K Buy
5,701
+285
+5% +$14.1K 0.19% 59
2025
Q3
$256K Sell
5,416
-60
-1% -$2.9K 0.18% 63
2025
Q2
$265K Buy
5,476
+257
+5% +$13.1K 0.2% 57
2025
Q1
$289K Sell
5,219
-927
-15% -$50.2K 0.23% 52
2024
Q4
$296K Sell
6,146
-84
-1% -$4.27K 0.24% 54
2024
Q3
$359K Sell
6,230
-295
-5% -$15.9K 0.28% 47
2024
Q2
$317K Buy
6,525
+178
+3% +$8.59K 0.27% 49
2024
Q1
$308K Buy
6,347
+261
+4% +$12.7K 0.25% 51
2023
Q4
$303K Buy
+6,086
New +$298K 0.28% 48

Other funds holding SNY

Bruce G. Allen Investments's SNY Position: Q1 2026 in Review

Bruce G. Allen Investments increased its Sanofi (SNY) stake by 6.1% in Q1 2026, buying an estimated $16.3K and bringing the position to 6,051 shares worth $292K. The position accounts for 0.19% of the portfolio, ranked #56.

Bruce G. Allen Investments first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $359K in Q3 2024. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Bruce G. Allen Investments held 6,051 shares of Sanofi worth $292K as of Q1 2026.
  • Bruce G. Allen Investments bought 350 Sanofi shares in Q1 2026, an estimated $16.3K.
  • Sanofi made up 0.19% of Bruce G. Allen Investments's portfolio in Q1 2026, its #56 holding.
  • Bruce G. Allen Investments first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Sanofi position peaked at $359K in Q3 2024.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.